Continuous glucose monitoring for diabetes in peritoneal dialysis
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether using a continuous glucose monitor (a small device that checks blood sugar constantly) can help people with diabetes who are on peritoneal dialysis manage their blood sugar better. It might give a clearer picture of glucose levels than finger-prick tests alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have kidney disease caused by diabetes (diabetic nephropathy).
- Your diabetes is treated with insulin.
- You have been on peritoneal dialysis for at least 3 months.
- You do not have HIV, hepatitis B, or hepatitis C.
- You have not had a recent hospitalization for heart, metabolic, or infectious problems.
- You do not have cancer, are not pregnant, and have no allergies that would interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar in people with diabetes and gastroparesis (slow stomach emptying). If you have type 1 or type 2 diabetes and stomach symptoms, this could help doctors better understand your glucose patterns.
This study tests whether using a continuous glucose monitor (a small sensor that checks blood sugar levels throughout the day) can help improve diabetes control in people who are on peritoneal dialysis (a type of kidney dialysis done at home). It aims to see if this technology leads to better health outcomes.
This study tests whether continuous glucose monitors (CGMs) work accurately in people doing peritoneal dialysis with icodextrin solution. It may help you manage your diabetes better by showing your glucose levels in real time.
This study uses a continuous glucose monitor to check for undiagnosed diabetes in people on dialysis. If you participate, you will wear a small sensor for about 10 days and take a sugary drink test to see how your body handles sugar.
This study tests whether using a real-time continuous glucose monitor (a device that tracks your blood sugar continuously) helps improve blood sugar control in people with type 2 diabetes who also have chronic kidney disease (stages 3 and 4). If you qualify, you may get better insight into your glucose patterns, which could help you manage your diabetes more effectively.
Hear when a new Peritoneal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.